Clinical trials and the patients who participate in them are vital to developing new colorectal cancer treatments. Clinical trials are sometimes seen as a last option for patients, but they are not. While some patients seek trial participation because their previous treatment has not been successful, it is essential to consider clinical trials. There are ongoing clinical trials of treatments that target colorectal cancer with specific biomarkers, and multiple prior treatments may affect eligibility for participation.